KXIN
KAIXIN Doubles Share Payout for Taohaoche Deal After 70% Stock Slide
Kaixin will issue 10 million extra Class A shares to the seller of Hongkong Taohaoche after its stock fell from above $5.00 to under $1.50.
KXIN
Kaixin will issue 10 million extra Class A shares to the seller of Hongkong Taohaoche after its stock fell from above $5.00 to under $1.50.
EGAN
eGain grew fiscal 2026 revenue 3% to $91.1 million and lifted AI customer revenue 20%, but guided fiscal 2027 sales down to $84.5-$86.0 million.
ALB
Kent Masters hands over the CEO role to BHP's chief commercial officer and becomes executive chairman of the lithium producer.
NCPL
A Netcapital board member resigned immediately over the SEC's August 10 civil action and demanded D&O insurance and indemnification records within 10 business days.
USAR
The 8-K reports a completed acquisition, new debt, unregistered share issuance and a board change, alongside a September 3 amendment to the Serra Verde merger agreement.
TARS
Tarsus Pharmaceuticals has completed its acquisition of Alkeus, gaining worldwide rights to oral Stargardt disease candidate gildeuretinol.
NTLA
The CRISPR company drew $75 million at closing, with $325 million more tied to milestones ahead of a planned U.S. launch of lonvo-z in hereditary angioedema.
OXM
Tommy Bahama's owner posted $394M in Q2 sales and a $42M tariff refund boost, but lowered full-year sales and adjusted EPS guidance.
DPU
Shareholders backed a 200x supervoting Class B structure, a jump in authorized capital to $625 million and a share consolidation effective December 17, 2026.
SWBI
Firearm maker posted $112.6 million in fiscal Q1 net sales and $0.06 EPS versus a loss a year ago, and guided to roughly 10% sales growth in Q2.
PCVX
Vaxcyte named Luis Jodar CMO and David McAvoy CLO, and now expects OPUS-1 Phase 3 topline data by the end of October 2026.
AMBA
The edge AI chipmaker reported $108.1 million in fiscal Q2 revenue, narrowed its GAAP loss to $6.7 million and guided to $115-124 million for Q3.